These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 33428055)

  • 1. Neurological manifestations of coronavirus disease 2019: exploring past to understand present.
    Desai I; Manchanda R; Kumar N; Tiwari A; Kumar M
    Neurol Sci; 2021 Mar; 42(3):773-785. PubMed ID: 33428055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
    Maury A; Lyoubi A; Peiffer-Smadja N; de Broucker T; Meppiel E
    Rev Neurol (Paris); 2021; 177(1-2):51-64. PubMed ID: 33446327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
    Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
    J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
    Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
    Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurological manifestations of COVID-19, SARS and MERS.
    Verstrepen K; Baisier L; De Cauwer H
    Acta Neurol Belg; 2020 Oct; 120(5):1051-1060. PubMed ID: 32562214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurological complications of coronavirus and COVID-19.
    Carod-Artal FJ
    Rev Neurol; 2020 May; 70(9):311-322. PubMed ID: 32329044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).
    Harapan BN; Yoo HJ
    J Neurol; 2021 Sep; 268(9):3059-3071. PubMed ID: 33486564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum of Neurological Manifestations in Covid-19: A Review.
    Garg RK
    Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic.
    Sharifian-Dorche M; Huot P; Osherov M; Wen D; Saveriano A; Giacomini PS; Antel JP; Mowla A
    J Neurol Sci; 2020 Oct; 417():117085. PubMed ID: 32871412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 and Neurology: An Emerging Association.
    Gupta A; Yadav P; Kumar D
    Infect Disord Drug Targets; 2021; 21(8):e160921191570. PubMed ID: 33602080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological Complications of COVID-19: Underlying Mechanisms and Management.
    Shehata GA; Lord KC; Grudzinski MC; Elsayed M; Abdelnaby R; Elshabrawy HA
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on neurological manifestations of COVID-19.
    Yavarpour-Bali H; Ghasemi-Kasman M
    Life Sci; 2020 Sep; 257():118063. PubMed ID: 32652139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. nCoV-2019 infection induced neurological outcome and manifestation, linking its historical ancestor SARS-CoV and MERS-CoV: a systematic review and meta-analysis.
    Prakash A; Singh H; Sarma P; Bhattacharyya A; Dhibar DP; Balaini N; Shree R; Goyal M; Modi M; Medhi B
    Sci Rep; 2021 Jun; 11(1):12888. PubMed ID: 34145351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological and Neuropsychiatric Impacts of COVID-19 Pandemic.
    Roy D; Ghosh R; Dubey S; Dubey MJ; Benito-León J; Kanti Ray B
    Can J Neurol Sci; 2021 Jan; 48(1):9-24. PubMed ID: 32753076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Infection Leads to Neurological Dysfunction.
    Acharya A; Kevadiya BD; Gendelman HE; Byrareddy SN
    J Neuroimmune Pharmacol; 2020 Jun; 15(2):167-173. PubMed ID: 32447746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms.
    Shoraka S; Ferreira MLB; Mohebbi SR; Ghaemi A
    Front Immunol; 2021; 12():674922. PubMed ID: 34040615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological manifestations of COVID-19: a systematic review.
    Nepal G; Rehrig JH; Shrestha GS; Shing YK; Yadav JK; Ojha R; Pokhrel G; Tu ZL; Huang DY
    Crit Care; 2020 Jul; 24(1):421. PubMed ID: 32660520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging neurotropic features of SARS-CoV-2.
    Zhan WR; Huang J; Zeng PM; Tian WY; Luo ZG
    J Mol Cell Biol; 2021 Dec; 13(10):705-711. PubMed ID: 34289037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological manifestations of COVID-19: a systematic review and meta-analysis of proportions.
    Favas TT; Dev P; Chaurasia RN; Chakravarty K; Mishra R; Joshi D; Mishra VN; Kumar A; Singh VK; Pandey M; Pathak A
    Neurol Sci; 2020 Dec; 41(12):3437-3470. PubMed ID: 33089477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) on the nervous system. What can we expect from SARS -CoV-2?
    Monroy-Gómez J; Torres-Fernández O
    Biomedica; 2020 Oct; 40(Supl. 2):173-179. PubMed ID: 33152201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.